CHEGAEV, Konstantin
CHEGAEV, Konstantin
SCIENZA E TECNOLOGIA DEL FARMACO
Amphiphile NO-donor antioxidants as polivalent drugs
2006-01-01 MARINI E; LAZZARATO L; CHEGAEV K; FRUTTERO R; GASCO A
Evaluation of the targeting ability of folate containing liposomal nitrooxy-doxorubicin.
2015-01-01 Pedrini, I.; Costamagna, F.; Buondonno, I.; Salaroglio, I. C.; Rolando, B.; Chegaev, K.; Fruttero, R.; Riganti, C.; Arpicco, S.
IN VITRO CARDIOVASCULAR TOXICITY RISK ASSESSMENT OF NOVEL H2S-DONATING ANTHRACYCLINE
2017-01-01 Durante, M.; Frosini, M.; Fusi, F.; Riganti, Chiara; Gazzano, Elena; Chegaev, Konstantin; Saponara, S.
INCAPSULATED NO-GEMCITABINE: GASEOUS SOLUTION FOR MDR PANCREATIC CANCER
2019-01-01 Chegaev, K.; Masetto, F.; Gazzano, E.; Mullappily, N.; Rolando, B.; Donadelli, M.; Arpicco, S.; Riganti, C.; Fruttero, R.
MITOCHONDRIAL-TARGETING NITROOXYDOXORUBICIN: EFFECTS ON P-GLYCOPROTEIN AND ASSESSMENT OF THEIR VASCULAR EFFECTS
2014-01-01 Frosini Maria; Maestrini Vanessa; Neri Annalisa; Santulli Chiara; Brizi Claudia; Chegaev Konstantin; Riganti Chiara; Sgaragli Giampietro; Colabufo Nicola Antonio; Saponara Simona
MODIFIED DOXORUBICINS: "GASEOUS APPROACH" TO OVERCOME CARDIOTOXICITY AND MULTIDRUG RESISTANCE
2016-01-01 Chegaev, K.; Rolando, B.; Gazzano, E.; Riganti, C.; Fruttero, R.
Multitarget antioxidant NO-donor organic nitrates: a novel approach to overcome nitrates tolerance
2022-01-01 Elisabetta Marini, Marta Giorgis, Barbara Rolando, Konstantin Chegaev
Multitarget drugs: NO-donor doxorubicins
2012-01-01 Chegaev K.; Riganti C.; Rolando B.; Federico A.; Fruttero R.; Gasco A.
Multitarget Drugs: No-Donor Doxorubicins
2015-01-01 Chegaev, Konstantin; Riganti, Chiara; Gazzano, Elena; Rolando, Barbara; Fruttero, Roberta; Gasco, Alberto
NITRIC OXIDE DONOR DOXORUBICINS: A USEFUL STRATEGY TO ADDRESS THE PROBLEM OF MDR IN CANCER THERAPY
2012-01-01 Rolando B.; Riganti C.; Chegaev K.; Fruttero R.; Gasco A.
Nitric oxide donor-doxorubicins as mdr reversing agents
2014-01-01 E.Gazzano; K. Chegaev; Pedrini I.; Kopecka J. Rolando B.;Fruttero ; Arpicco S.; Ghigo D. Riganti C.
Nitric oxide release by an edavarone derivative containing NOdonor furoxan moiety contributes to the resolution of renal injury after ischemia/reperfusion in the rat
2013-01-01 F. Chiazza; M. Rogazzo; E. Benetti; K. Chegaev; A. Di Stilo; R. Fruttero; J.C. Cutrin;R . Fantozzi; M. Collino
Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance.
2013-01-01 Joanna Kopecka; Chiara Riganti; Barbara Rolando; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo
NO donor - melatonins: a new class of potential antiatherosclerosis agents
2005-01-01 CHEGAEV K; LAZZARATO L; GIORGIS M; CENA C; DI STILO A; FRUTTERO R; GASCO A; LUCINI V; PANNACI M
NO-Donor Cyanines As Potential Anti-Alzheimer Drugs
2011-01-01 Federico A.; Chegaev K.; Lazzarato L.; Marini E.; Fruttero R.; Gasco A.
NO-Donor Furoxans Containing a Sulphonamide Moiety and Related Furazans as Potent Carbonic Anhydrase Inhibitors
2010-01-01 Roberta Fruttero; Loretta Lazzarato; Konstantin Chegaev; Barbara Rolando; Donatella Boschi; Claudiu T. Supuran; Alessio Innocenti; Alberto Gasco
Novel amphiphilic nitric oxide releasing antioxidants: NMR spectroscopic study of their interaction with biomembrane models
2005-01-01 LOPEZ V; LAZZARATO L; CHEGAEV K; ROLANDO B; FRUTTERO R; GASCO A
Novel NO-donor Doxorubicins
2014-01-01 Daniela Cortese; Konstantin Chegaev; Chiara Riganti; Barbara Rolando; Roberta Fruttero; Alberto Gasco.
Novel Organic Nitrate Esters
2002-01-01 TRON G.C; DI STILO A; K. CHEGAEV; SORBA G; FRUTTERO R; GASCO A
NOVEL SEMISYNTHETIC DOXORUBICINS WITH REDUCED CARDIOTOXICITY
2013-01-01 Konstantin Chegaev; Loretta Lazzarato; Barbara Rolando; Chiara Riganti; Roberta Fruttero; Alberto Gasco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Amphiphile NO-donor antioxidants as polivalent drugs | 2006 | MARINI E; LAZZARATO L; CHEGAEV K; FRUTTERO R; GASCO A | |
| Evaluation of the targeting ability of folate containing liposomal nitrooxy-doxorubicin. | 2015 | Pedrini, I.; Costamagna, F.; Buondonno, I.; Salaroglio, I. C.; Rolando, B.; Chegaev, K.; Fruttero, R.; Riganti, C.; Arpicco, S. | |
| IN VITRO CARDIOVASCULAR TOXICITY RISK ASSESSMENT OF NOVEL H2S-DONATING ANTHRACYCLINE | 2017 | Durante, M.; Frosini, M.; Fusi, F.; Riganti, Chiara; Gazzano, Elena; Chegaev, Konstantin; Saponara, S. | |
| INCAPSULATED NO-GEMCITABINE: GASEOUS SOLUTION FOR MDR PANCREATIC CANCER | 2019 | Chegaev, K.; Masetto, F.; Gazzano, E.; Mullappily, N.; Rolando, B.; Donadelli, M.; Arpicco, S.; Riganti, C.; Fruttero, R. | |
| MITOCHONDRIAL-TARGETING NITROOXYDOXORUBICIN: EFFECTS ON P-GLYCOPROTEIN AND ASSESSMENT OF THEIR VASCULAR EFFECTS | 2014 | Frosini Maria; Maestrini Vanessa; Neri Annalisa; Santulli Chiara; Brizi Claudia; Chegaev Konstantin; Riganti Chiara; Sgaragli Giampietro; Colabufo Nicola Antonio; Saponara Simona | |
| MODIFIED DOXORUBICINS: "GASEOUS APPROACH" TO OVERCOME CARDIOTOXICITY AND MULTIDRUG RESISTANCE | 2016 | Chegaev, K.; Rolando, B.; Gazzano, E.; Riganti, C.; Fruttero, R. | |
| Multitarget antioxidant NO-donor organic nitrates: a novel approach to overcome nitrates tolerance | 2022 | Elisabetta Marini, Marta Giorgis, Barbara Rolando, Konstantin Chegaev | |
| Multitarget drugs: NO-donor doxorubicins | 2012 | Chegaev K.; Riganti C.; Rolando B.; Federico A.; Fruttero R.; Gasco A. | |
| Multitarget Drugs: No-Donor Doxorubicins | 2015 | Chegaev, Konstantin; Riganti, Chiara; Gazzano, Elena; Rolando, Barbara; Fruttero, Roberta; Gasco, Alberto | |
| NITRIC OXIDE DONOR DOXORUBICINS: A USEFUL STRATEGY TO ADDRESS THE PROBLEM OF MDR IN CANCER THERAPY | 2012 | Rolando B.; Riganti C.; Chegaev K.; Fruttero R.; Gasco A. | |
| Nitric oxide donor-doxorubicins as mdr reversing agents | 2014 | E.Gazzano; K. Chegaev; Pedrini I.; Kopecka J. Rolando B.;Fruttero ; Arpicco S.; Ghigo D. Riganti C. | |
| Nitric oxide release by an edavarone derivative containing NOdonor furoxan moiety contributes to the resolution of renal injury after ischemia/reperfusion in the rat | 2013 | F. Chiazza; M. Rogazzo; E. Benetti; K. Chegaev; A. Di Stilo; R. Fruttero; J.C. Cutrin;R . Fantozzi; M. Collino | |
| Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance. | 2013 | Joanna Kopecka; Chiara Riganti; Barbara Rolando; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo | |
| NO donor - melatonins: a new class of potential antiatherosclerosis agents | 2005 | CHEGAEV K; LAZZARATO L; GIORGIS M; CENA C; DI STILO A; FRUTTERO R; GASCO A; LUCINI V; PANNACI M | |
| NO-Donor Cyanines As Potential Anti-Alzheimer Drugs | 2011 | Federico A.; Chegaev K.; Lazzarato L.; Marini E.; Fruttero R.; Gasco A. | |
| NO-Donor Furoxans Containing a Sulphonamide Moiety and Related Furazans as Potent Carbonic Anhydrase Inhibitors | 2010 | Roberta Fruttero; Loretta Lazzarato; Konstantin Chegaev; Barbara Rolando; Donatella Boschi; Claudiu T. Supuran; Alessio Innocenti; Alberto Gasco | |
| Novel amphiphilic nitric oxide releasing antioxidants: NMR spectroscopic study of their interaction with biomembrane models | 2005 | LOPEZ V; LAZZARATO L; CHEGAEV K; ROLANDO B; FRUTTERO R; GASCO A | |
| Novel NO-donor Doxorubicins | 2014 | Daniela Cortese; Konstantin Chegaev; Chiara Riganti; Barbara Rolando; Roberta Fruttero; Alberto Gasco. | |
| Novel Organic Nitrate Esters | 2002 | TRON G.C; DI STILO A; K. CHEGAEV; SORBA G; FRUTTERO R; GASCO A | |
| NOVEL SEMISYNTHETIC DOXORUBICINS WITH REDUCED CARDIOTOXICITY | 2013 | Konstantin Chegaev; Loretta Lazzarato; Barbara Rolando; Chiara Riganti; Roberta Fruttero; Alberto Gasco |